OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant Immunotherapy for Localized Pancreatic Cancer: Challenges and Early Results
Robert C. Chick, Andrew J. Gunderson, Shafia Rahman, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3967-3967
Open Access | Times Cited: 11
Robert C. Chick, Andrew J. Gunderson, Shafia Rahman, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3967-3967
Open Access | Times Cited: 11
Showing 11 citing articles:
Neoadjuvant systemic therapy for hepatocellular carcinoma
Robert C. Chick, Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Robert C. Chick, Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Evidence and Future Perspectives for Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Scoping Review
Yutaka Endo, Minoru Kitago, Yuko Kitagawa
Cancers (2024) Vol. 16, Iss. 9, pp. 1632-1632
Open Access | Times Cited: 5
Yutaka Endo, Minoru Kitago, Yuko Kitagawa
Cancers (2024) Vol. 16, Iss. 9, pp. 1632-1632
Open Access | Times Cited: 5
Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy
Yu Xiao, Tao Pan, Wuren Da, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Yu Xiao, Tao Pan, Wuren Da, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting
Kaili Liang, Nilofer S. Azad
Cancers (2025) Vol. 17, Iss. 7, pp. 1246-1246
Open Access
Kaili Liang, Nilofer S. Azad
Cancers (2025) Vol. 17, Iss. 7, pp. 1246-1246
Open Access
Recent Advances and Challenges in the Treatment of Advanced Pancreatic Cancer: An Update on Completed and Ongoing Clinical Trials
Archana Shenoy, Amar Yousif, Muhammad Delwar Hussain
Cancers (2025) Vol. 17, Iss. 8, pp. 1319-1319
Open Access
Archana Shenoy, Amar Yousif, Muhammad Delwar Hussain
Cancers (2025) Vol. 17, Iss. 8, pp. 1319-1319
Open Access
Advancements in neoadjuvant immune checkpoint inhibitor therapy for locally advanced head and neck squamous Carcinoma: A narrative review
Jin Li, Zhenqin Luo, Siqing Jiang, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112200-112200
Open Access | Times Cited: 2
Jin Li, Zhenqin Luo, Siqing Jiang, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112200-112200
Open Access | Times Cited: 2
Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma
Shiqiong Zhou, Peng Wan, Sen Zhang, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 7, pp. 859-866
Open Access | Times Cited: 2
Shiqiong Zhou, Peng Wan, Sen Zhang, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 7, pp. 859-866
Open Access | Times Cited: 2
Updates in Immunotherapy for Pancreatic Cancer
Robert C. Chick, Timothy M. Pawlik
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6419-6419
Open Access | Times Cited: 1
Robert C. Chick, Timothy M. Pawlik
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6419-6419
Open Access | Times Cited: 1
Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (PDAC)
Sepideh Hajivalizadeh, Shahin Akhondzadeh
Journal of Iranian Medical Council (2024)
Open Access
Sepideh Hajivalizadeh, Shahin Akhondzadeh
Journal of Iranian Medical Council (2024)
Open Access
Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study
Zhitao Chen, Yahui He, Chenchen Ding, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 923-935
Open Access | Times Cited: 1
Zhitao Chen, Yahui He, Chenchen Ding, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 923-935
Open Access | Times Cited: 1
Molecular underpinnings of pancreatic cancer: Innovations in treatment and future perspectives
Mesut Tez, Eda Şahingöz, Fahri Martlı
Gastrointestinal Tract (2023) Vol. 1
Open Access
Mesut Tez, Eda Şahingöz, Fahri Martlı
Gastrointestinal Tract (2023) Vol. 1
Open Access
